Date: Thursday, May 5, 2022
Time: 7:00 pm - 8:30 pm

Stelfonta is a novel therapeutic for the treatment of mast cell disease in dogs. This treatment was recently licensed for the use in dogs and is now available to all veterinary practitioners. Dr. Swanson will discuss this therapy, the indications and her experience managing these cases.

 Here are the quick details:

• This meeting is limited to member veterinarians and technicians only.       
• After registration with the WMVMA, you will receive an email from Blue Pearl with a link to the webinar. 

About our speaker:

On The Job

Dr. Christine Swanson is especially interested in combination chemotherapy as extracted from human medicine.

Education

• Diplomate, American College of Veterinary Internal Medicine (Oncology)
• Residency, Oncology, Michigan State University, East Lansing
• Internship, Small Animal Medicine & Surgery, Michigan Veterinary Specialists, Southfield
• Doctor of Veterinary Medicine, Michigan State University, East Lansing
• Bachelor’s of Science, Michigan State University, East Lansing

Off Duty